Blueprint Annoucement - Blueprint Annoucement - POCTRN
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
Up to 100K and Mentorship Available for Innovative Neurotechnologies
Apply By June 21
In support of the Blueprint MedTech Pilot, the POCTRN at CIMIT seeks groundbreaking collaborative research projects in the early stages of translation to improve the diagnosis and/or treatment of disorders of the nervous system. Applications must present potentially transformative solutions to unmet needs with an ultimate goal of improving healthcare outcomes. If successful, projects should be viable candidates for commercial development.
Awards up to $100K are available to the most promising and innovative neurotechnologies to help support their development journey toward commercialization.
Awardees will also have the unique opportunity to work directly with mentors experienced in commercializing neurotech devices to help address project related business, regulatory, clinical, and technical issues.
Pre-proposals are due no later than: June 21